Key Takeaways
- Raymond James launched coverage on RKLB with an “Outperform” designation and $80 target price, suggesting potential gains exceeding 25%.
- The company’s backlog reached $2.36 billion, representing a 137% increase from the prior year, while quarterly sales climbed 62% to $234.1 million.
- Major institutional players like BlackRock and Bank of America established substantial new stakes in Q2; institutional ownership now stands at 71.78%.
- Insider transactions raise questions, with company executives offloading over $312 million in shares during the last 90 days.
- Wall Street consensus points to “Moderate Buy” with an average target price of $107.32.
Shares of Rocket Lab (RKLB) are currently changing hands at prices more than 55% beneath their year-to-date peak, yet renewed interest from Wall Street analysts suggests a potential turnaround.
On September 11, Raymond James analyst Brian Gesuale launched coverage with an “Outperform” designation alongside an $80 target price. This projection represents potential gains of more than 25% based on trading levels when the research note was published.
Gesuale’s investment thesis emphasizes that Rocket Lab extends far beyond traditional launch operations. The firm has developed comprehensive end-to-end mission solutions, delivering components, software platforms, and satellite infrastructure for civil, commercial, and national security applications.
This diversified revenue model, blending launch operations with space systems technology, generates stable recurring income streams unavailable to pure-play launch competitors.
The analyst contends that current market valuations fail to reflect RKLB’s extended earnings trajectory as government defense and scientific contracts expand.
Unprecedented Backlog and Revenue Acceleration
Rocket Lab closed its latest reporting period with contracted backlog totaling $2.36 billion, representing a 137% surge versus the comparable year-earlier period. This level of forward revenue visibility remains uncommon for companies at this growth stage.
Revenue for the quarter reached $234.1 million, marking a 62% year-over-year increase. The company maintains cash holdings exceeding $2 billion.
Raymond James highlighted these metrics as confirmation that market pricing hasn’t fully incorporated the company’s extended earnings power.
The company recently achieved its 95th Electron mission, successfully delivering an Earth-observation satellite to a 500-kilometer orbital altitude. This marked the firm’s 16th launch in the current year, with an additional commercial mission scheduled before September concludes.
Institutional Accumulation Contrasts with Executive Sales
Significant institutional capital has flowed into RKLB shares. Virginia Retirement Systems purchased 10,539 shares during Q2, valued at approximately $1.07 million. BlackRock established a fresh position valued near $4.1 billion. Bank of America initiated a stake worth around $437 million. Institutional ownership currently represents 71.78% of outstanding shares.
Conversely, company insiders have reduced holdings substantially. Throughout the previous 90 days, insiders liquidated over $312 million in stock through 97 separate transactions, with no recorded purchases. CEO Peter Beck participated in these sales.
While some transactions occurred under pre-established Rule 10b5-1 trading plans and related to tax liabilities from equity compensation vesting, the overall magnitude remains noteworthy.
Raymond James isn’t the only firm expressing optimism. Berenberg Bank initiated coverage September 2 with a “Buy” recommendation and $83 price objective. Citizens JMP maintains a $130 target. The analyst community consensus registers as “Moderate Buy” with a mean projection of $107.32.
Weiss Ratings stands as one outlier maintaining a “Sell” stance. Piper Sandler holds a “Neutral” rating with an $83 target.
Current analyst coverage includes four “Strong Buy” recommendations, fourteen “Buy” ratings, five “Hold” positions, and one “Sell” rating.


